MetLife vs Prudential Financial
MET and PRU side by side, both in life insurance. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MET and PRU compare
MetLife is the larger company, worth 1.5 times as much as Prudential Financial ($64.5B against $42.4B).
On earnings, Prudential Financial is cheaper: it trades at 11.1× trailing earnings, against 13.2× for MetLife.
MetLife grew revenue faster over the last twelve months (14.8% versus 9.4% for Prudential Financial).
MetLife keeps more of each dollar of sales as profit, with a net margin of 6.2% compared with 6.0% at Prudential Financial.
Both pay dividends: MetLife yields 1.7% and Prudential Financial 4.5%.
Prudential Financial scores higher on the StockData Score (11 against 10 for MetLife), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MET | PRU |
|---|---|---|
| Size and price | ||
| Market cap | $64.5B | $42.4B |
| Share price | $101.45 | $122.91 |
| Change, 1 year | 27.7% | 14.0% |
| Change, 5 years | 68.8% | 16.9% |
| Beta (5Y) | 0.68 | 0.36 |
| Employees | 46K | 52K |
| StockData Score | ||
| Total score | 10 | 11 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 2 | 2 |
| Health score | 2 (better) | 1 |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 13.2× | 11.1× (better) |
| P/S | 0.8× | 0.7× (better) |
| P/B | 2.9× | 1.3× (better) |
| EV/EBITDA | 5.5× (better) | 10.2× |
| Fair value | $74.42 | $127.80 |
| Margin of safety | −36.3% | 3.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 14.8% (better) | 9.4% |
| Revenue growth, 5Y average | 2.6% (better) | 1.3% |
| Net income growth (TTM) | 33.5% | 140% (better) |
| EPS growth (TTM) | 44.4% | 144% (better) |
| EPS growth, 5Y average | −3.7% | – |
| Profitability | ||
| Operating margin | 8.2% | – |
| Net margin | 6.2% (better) | 6.0% |
| Return on equity | 20.0% (better) | 12.6% |
| Financial health | ||
| Debt / equity | 0.01 (better) | 0.65 |
| Net debt / EBITDA | −4.06 | 1.15 (better) |
| Altman Z-score | 0.28 (better) | 0.18 |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 1.7% | 4.5% (better) |
| Payout ratio | 29.4% | 49.7% |
| Years of dividend growth | 13 (better) | 12 |
| Dividend growth, 5Y average | 4.3% (better) | 4.2% |
| Buyback yield | 4.0% (better) | 2.4% |
| Shareholder yield | 5.7% | 6.9% (better) |
| Ownership | ||
| Held by institutions | 76.5% | 63.4% |
| Held by insiders | 16.1% | 0.25% |
| Insider net buying, 12 months | −$21.0M | −$4.9M (better) |
| Short interest, % of float | 2.0% | – |
Go deeper
- MET stock overview
- MET income statement
- MET valuation and score
- PRU stock overview
- PRU income statement
- PRU valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.